methylprednisolone sodium succinate

Poland

Drugs containing this active substance

  • MEPRELON

    The drug is used in conditions requiring very rapid action of glucocorticosteroids, such as: severe asthma attack, cerebral edema, severe allergic reactions, certain acute skin diseases, blood disorders, acute hepatitis, toxic pulmonary edema, and adrenal insufficiency.

    Form: solution for injection / infusion, powder and solvent for preparation of

    Active substance Dosage
    methylprednisolone sodium succinate No input provided

    ATC: H02AB04

    Manufacturer: mibe GmbH Pharmaceuticals

  • The medicine is used in conditions requiring very rapid action of glucocorticosteroids, such as: severe acute asthma attack, cerebral edema, severe allergic reaction, acute blood or liver disorders, as well as in cases of adrenal insufficiency.

    Form: solution for injection / infusion, powder and solvent for preparation of

    Active substance Dosage
    methylprednisolone sodium succinate No input provided

    ATC: H02AB04

    Manufacturer: mibe GmbH Pharmaceuticals

  • The medicinal product is used to treat many diseases, including endocrine disorders (e.g., adrenal insufficiency), rheumatic diseases, skin diseases, allergies, eye diseases, respiratory diseases, cancers (to improve quality of life), and to prevent nausea and vomiting during chemotherapy.

    Form: solution for injection, powder and solvent for preparation of

    Active substance Dosage
    methylprednisolone sodium succinate 53.03 mg

    ATC: H02AB04

    Manufacturer: Sopharma AD

  • The medicine is used for many conditions, including rheumatic diseases (e.g., rheumatoid arthritis), dermatological diseases (e.g., severe psoriasis, pemphigus), allergic diseases (e.g., asthma), eye diseases, respiratory diseases, blood diseases, neoplasms (palliative treatment), as well as in cases of edema and endocrine disorders.

    Form: solution for injection, powder and solvent for preparation of

    Active substance Dosage
    methylprednisolone sodium succinate 331.48 mg

    ATC: H02AB04

    Manufacturer: Sopharma AD

  • Metypred is used for the symptomatic treatment of many conditions, such as rheumatic diseases, systemic connective tissue diseases, dermatological diseases, allergic diseases, eye diseases, respiratory diseases, blood diseases, gastrointestinal diseases, and nervous system diseases. It is also used for replacement therapy in endocrine disorders and for palliative treatment of certain cancers.

    Form: tablets

    Active substance Dosage
    methylprednisolone sodium succinate 4 mg

    ATC: H02AB04

    Manufacturer: Orion Corporation Orion Pharma

  • The drug is used to treat, among others, rheumatic diseases (e.g., rheumatoid arthritis), connective tissue diseases (e.g., lupus), dermatological diseases (e.g., psoriasis), allergies (e.g., asthma), eye diseases, respiratory system diseases, blood diseases, gastrointestinal diseases, and in the treatment of endocrine disorders.

    Form: tablets

    Active substance Dosage
    methylprednisolone sodium succinate 16 mg

    ATC: H02AB04

    Manufacturer: Orion Corporation Orion Pharma

  • The drug is used to treat, among others, endocrinological disorders (e.g., adrenal insufficiency), rheumatic diseases, connective tissue diseases, dermatological diseases, allergic diseases, eye diseases, gastrointestinal diseases, respiratory diseases, hematological diseases, neoplastic diseases, as well as to reduce cerebral edema or during organ transplantation.

    Form: solution for injection, powder and solvent for preparation of

    Active substance Dosage
    methylprednisolone sodium succinate 1000 mg

    ATC: H02AB04

    Manufacturer: Pfizer Manufacturing Belgium NV